Nintoin 25 mg/5 ml (Oral Suspension)
100 ml bottle: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Nitrofurantoin |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Treatment of urinary tract infections
- Prophylaxis of urinary tract infections
- Target bacteria: Escherichia coli
- Target bacteria: Enterococci
- Target bacteria: Staphylococcus aureus
- Target bacteria: Staphylococcus saprophyticus
- Target bacteria: Klebsiella species
- Target bacteria: Enterobacter species
Pharmacology
- Specific for urinary tract infections
- Highly soluble in urine
- Inactivation of bacterial ribosomal proteins
- Activity against Gram-Positive Aerobes
- Activity against Gram-Negative Aerobes
Dosage
- Dosage for uncomplicated urinary tract infections in adults
- Dosage for long-term suppressive therapy in adults
- Dosage for acute uncomplicated urinary tract infections in adults
- Dosage for long term suppression in adults
- Dosage for prophylaxis in adults
- Dosage for genito-urinary surgical prophylaxis in adults
- Dosage for pediatric patients
- Average doses for pediatric patients based on weight
Administration
- Should be taken with food
Interaction
- Interaction with antacids containing Magnesium Trisilicate
- Interaction with uricosuric drugs like Probenecid and Sulfinpyrazone
Contraindications
- Contraindicated in anuria, oliguria, or significant impairment of renal function
- Contraindicated in pregnant patients at 38-42 weeks, during labor and delivery
- Contraindicated in patients with known hypersensitivity to Nitrofurantoin
Side Effects
- Frequent adverse events: nausea, headache, flatulence
- Less frequent adverse events: diarrhea, dyspepsia, abdominal pain, constipation, emesis, dizziness, drowsiness
Pregnancy & Lactation
- Pregnancy Category B
- Limited data on usage during pregnancy
- Detection in human breast milk in trace amounts
- Consideration for nursing infants under one month of age
Precautions & Warnings
- Discontinuation if pulmonary reactions occur
- Avoidance of antacid preparations containing magnesium trisilicate
Overdose Effects
- Occasional incidents of vomiting in acute overdosage
- Induction of emesis recommended
Therapeutic Class
- Systemic Urinary Anti-infective
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children
Related Brands
- Uritro 25 mg/5 ml (Oral Suspension) - team-pharmaceuticals-ltd
- Furabac 100 mg (Capsule (Sustained Release)) - popular-pharmaceuticals-ltd
- NFT 25 mg/5 ml (Oral Suspension) - healthcare-pharmaceuticals-ltd
- NFT 100 mg (Capsule (Sustained Release)) - healthcare-pharmaceuticals-ltd
- Urobak SR 100 mg (Capsule (Sustained Release)) - opsonin-pharma-ltd